An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)

Hepatitis D, Chronic Clinical Trial

Official title:
National, Multicenter, Observational Study Evaluating Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta in Romania and Assess Efficacy of Peg-interferon Alfa-2a Treatment in Patients With Chronic Hepatitis D (CHD)

Status Terminated

Clinical Trial Summary

This prospective, multicenter, observational study will assess the prevalence of chronic hepatitis D in patients with chronic hepatitis B in Romania and evaluate the efficacy of Pegasys (peginterferon alfa-2a) in patients with chronic hepatitis D. Eligible patients treated with Pegasys according to current medical practice will be followed until 24 weeks after the end of treatment.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01861444
Study type	Observational
Source	Hoffmann-La Roche
Contact
Status	Terminated
Phase	N/A
Start date	March 2011
Completion date	March 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05461170` - SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.	Phase 2
Active, not recruiting	`NCT04535544` - A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus	Phase 2
Completed	`NCT02732639` - A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)	Phase 3
Completed	`NCT02731131` - A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)	Phase 2
Completed	`NCT02765802` - A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection	Phase 2
Active, not recruiting	`NCT05229991` - Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection	Phase 3
Active, not recruiting	`NCT03105310` - Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D	Phase 2
Recruiting	`NCT04166266` - Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection
Completed	`NCT01088659` - A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.	Phase 3
Completed	`NCT00686790` - Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)	Phase 3
Completed	`NCT02876419` - A Long Term Follow-up Study of Patients From the REP 301 Protocol